The initial Cochrane critique on this matter (Yelland 2004B) was conducted to target entirely on prolotherapy injections, adhering to an earlier Cochrane critique of all injection therapies for minimal‐back pain (Nelemans 2003) during which the one therapy that confirmed considerable, sustained reductions in pain and incapacity at six months https://whatisconolidine01234.pointblog.net/top-guidelines-of-use-proleviate-for-back-pain-67862574